|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 4206 | Drugs / Medical | 03/01/2005
Kahn Gauthier Swick is seeking to file a lawsuit on behalf of persons that have certain Medtronic implantable heart devices. These products were surgically implanted in persons that are either prone to life-threatening heart rhythms, congestive heart failure or a combination of both.
However, on February 11, 2005 Medtronic Inc. issued a statement that the company was voluntarily advising physicians about a potential battery shorting mechanism in certain implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillators (CRT-D) models. This could cause the battery to experience a rapid depletion of power resulting in the loss of device function. This would prevent the device from correcting the abnormal heart rhythm. If you or a loved one believe you have one of these heart devices please contact the Kahn Gauthier Swick for more Medtronic lawsuit information. ICDs shock the heart back into a regular rhythm if the patient suffers a life threatening arrhythmia that could lead to cardiac arrest. CRT-Ds provide electrical impulses to improve heart function. The particular ICDs and CRT-Ds were manufactured between April 2001 and December 2003 and include the following: Model 7230 Marquis™ VR These are the only models that are affected. Please contact Kahn Gauthier today by either calling us at 1-866-467-1400 or clicking on this page to make a claim if you believe that you have one these ICDs or CRT-Ds or if your physician has contacted you regarding having your ICD or CRT-D replaced. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest The parties have reached a $50 million settlement in an administrative action filed against pharmaceutical company Bristol-Myers Squibb Company (NYSE:BMY) filed by the U.S. Securities and Exchange Commission. The action alleged that, from the first quarter of 2000 through the fourth quarter of 2001, Bristol-Myers engaged in a fraudulent scheme to overstate its sales and earnings in order to create the false appearance that the company had met or exceeded financial projections set by its officers and earnings estimates established by Wall Street securities analysts. Persons who purchased, sold, or held Bristol-Myers stock during that period may contact the attorneys who prosecuted the case for more information. In this day of incurable transmissible diseases, it would be nice to be confident that the needle that gets stuck in your arm has never been used before. On November 5, 2003, the court granted preliminary approval to the parties' $25 million proposed settlement in a class action filed against Oklahoma's Norman Regional Hospital, a clinic administrator, and nurse anesthetist James Hill who is accused of reusing needles when administering intravenous pain medicine to patients in the hospital's clinic in violation of state medical regulations. We still don't know who sent those two letters filled with anthrax that killed two U.S. Postal workers in Washington, D.C. A $100 million class action has been filed against the U.S. Postmaster General John E. Potter and several other administrative personnel at the U.S. Postal Service processing and distribution center on Brentwood Road in Northeast Washington on behalf of Brentwood postal workers who allege that their Fifth Amendment right to due process of law under the U.S. Constitution was violated when they were exposed to anthrax but not treated in the same efficient manner as victims on Capitol Hill who were exposed when a letter containing the deadly virus was opened in the office of Senator Tom Daschle on October 14, 2001. A class action lawsuit was filed in federal court in Baton Rouge that claims a New York medical supply company sold illegal tissue and bone to Baton Rouge hospital Our Lady of the Lake Regional Medical Center and other unnamed hospitals in Louisiana. Darrel Bourque says surgeons notified him in January that tissue transplanted in his neck during spinal surgery a year ago came from Biomedical Tissue Services.
The parties have reached a $35+ million USD settlement in three class actions filed against Dow Corning on behalf of Canadians who claim that silicone surgical implants have caused them health problems, in violation of Canadian consumer protection statutes. There are numerous claims deadlines that range from August 30, 2004, to June 3, 2019, depending on the type of claim that is being filed. Persons eligible to take part in the settlements should visit the settlement websites for more information. Ten women filed a lawsuit against Johnson & Johnson and its subsidiary Ortho McNeil on July 25, 2005, claiming the birth control device the company manufactures caused them to suffer strokes and blood clots.
|
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
